Answers are grounded in this paper and cite their sources.
Tacrolimus trough concentrations are essential after kidney transplantation but do not describe the dose required to achieve them. The concentration-to-dose (C/D) ratio adds this denominator and provides a low-cost, time-dependent dose-requirement phenotype from routine data. A low C/D ratio identifies recipients with high dose requirements and is associated with impaired kidney function, rejection, BK virus complications, graft failure, and mortality. Large registry data show graded risk as the C/D ratio decreases and more favorable outcomes when the low C/D ratio normalizes than when it remains low. The C/D ratio can therefore support risk stratification and selective area under the concentration-time curve value-based exposure assessment, but it is not a stand-alone treatment algorithm: interpretation requires valid sampling, assay, timing, formulation, and clinical context, and the outcome benefit from a C/D ratio-guided intervention remains unproven.
No takes yet. Share an insight, caveat, or question.
Reuter et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: